SEC Form 4 · accession 0001209191-17-045853
PORTOLA PHARMACEUTICALS INC · PTLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John T Curnutte
Officer — Executive Vice President
Period of report
Jul 18, 2015
Accepted (ET)
Jul 20, 2017 · 6:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 18, 2017 | M | 10,000 | $8.50 | A | 10,000 | D | |
| Common StockF1 | Jul 18, 2017 | S | 10,000 | $65.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $8.50 | Jul 18, 2017 | M | 10,000 | D | Mar 23, 2011 | Mar 23, 2021 | Common Stock | 10,000 | 1,918 | D |
Explanation of responses
- F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 20, 2017.